tiprankstipranks
Trending News
More News >
Genmab A/S (GB:0MGB)
LSE:0MGB
Advertisement

Genmab A/S (0MGB) Stock Statistics & Valuation Metrics

Compare
10 Followers

Total Valuation

Genmab A/S has a market cap or net worth of kr97.03B. The enterprise value is kr63.39B.
Market Capkr97.03B
Enterprise Valuekr63.39B

Share Statistics

Genmab A/S has 64,158,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding64,158,810
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Genmab A/S’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 14.10%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)14.10%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee8.16M
Profits Per Employee2.97M
Employee Count2,638
Asset Turnover0.47
Inventory Turnover15.89

Valuation Ratios

The current PE Ratio of Genmab A/S is 11.4. Genmab A/S’s PEG ratio is ―.
PE Ratio11.4
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.63
Price to FCF0.00
Price to Operating Cash Flow19.09
PEG Ratio

Income Statement

In the last 12 months, Genmab A/S had revenue of 21.53B and earned 7.84B in profits. Earnings per share was 122.21.
Revenue21.53B
Gross Profit20.54B
Operating Income6.70B
Pretax Income9.16B
Net Income7.84B
EBITDA9.70B
Earnings Per Share (EPS)122.21

Cash Flow

In the last 12 months, operating cash flow was 5.09B and capital expenditures -182.00M, giving a free cash flow of 4.91B billion.
Operating Cash Flow5.09B
Free Cash Flow4.91B
Free Cash Flow per Share76.56

Dividends & Yields

Genmab A/S pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.98
52-Week Price Change-14.47%
50-Day Moving Average1.41K
200-Day Moving Average1.43K
Relative Strength Index (RSI)68.24
Average Volume (3m)12.35K

Important Dates

Genmab A/S upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date

Financial Position

Genmab A/S as a current ratio of 5.25, with Debt / Equity ratio of 2.79%
Current Ratio5.25
Quick Ratio5.24
Debt to Market Cap<0.01
Net Debt to EBITDA-0.91
Interest Coverage Ratio55.86

Taxes

In the past 12 months, Genmab A/S has paid 1.32B in taxes.
Income Tax1.32B
Effective Tax Rate0.14

Enterprise Valuation

Genmab A/S EV to EBITDA ratio is 9.04, with an EV/FCF ratio of 11.56.
EV to Sales4.07
EV to EBITDA9.04
EV to Free Cash Flow11.56
EV to Operating Cash Flow11.28

Balance Sheet

Genmab A/S has kr18.43B in cash and marketable securities with kr143.00M in debt, giving a net cash position of -kr17.48B billion.
Cash & Marketable Securitieskr18.43B
Total Debtkr143.00M
Net Cash-kr17.48B
Net Cash Per Share-kr272.52
Tangible Book Value Per Sharekr337.58

Margins

Gross margin is 94.63%, with operating margin of 31.14%, and net profit margin of 36.44%.
Gross Margin94.63%
Operating Margin31.14%
Pretax Margin42.57%
Net Profit Margin36.44%
EBITDA Margin45.05%
EBIT Margin43.13%

Analyst Forecast

The average price target for Genmab A/S is kr1,993.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Targetkr1,993.75
Price Target Upside26.39% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis